Human medicines European public assessment report (EPAR): Ilumira, lutetium (177Lu) chloride, Status: Opinion
Human medicines European public assessment report (EPAR): Kayshild, semaglutide, Status: Opinion
Human medicines European public assessment report (EPAR): Kygevvi, doxecitine,doxribtimine, Status: Opinion
Summary of opinion: Noxafil, 29/01/2026 Positive
Summary of opinion: Kerendia, 29/01/2026 Positive
Summary of opinion: Eurneffy, 29/01/2026 Positive
Summary of opinion: Iclusig, 29/01/2026 Positive
Summary of opinion: Zynyz, 29/01/2026 Positive
Summary of opinion: Efmody, 29/01/2026 Positive
Summary of opinion: Akeega, 29/01/2026 Positive